Vacaville's Large Scale signs deal with BioCatalytics
LATEST NEWS
San Francisco Business Times - 10:02 AM PDT Thursday
Large Scale signs deal with BioCatalytics
Large Scale Biology Corp. and BioCatalytics Inc. have signed a multi-year collaboration and license agreement to develop improved enzymes for chemical synthesis.
Under terms of the deal BioCatalytics of Pasadena will pay a commercial license fee to Vacaville's Large Scale Biology (NASDAQ:LSBC) for use of its protein improvement technologies. Large Scale also will receive royalties on sales of products developed by BioCatalytics. Further details of the deal were not disclosed.
BioCatalytics believes the deal will yield a series of "next-generation" enzymes that can be used to make new chemical intermediates and drugs. Large Scale develops compounds and industrial proteins used in drug development and research.
East Bay Business Times
San Francisco Business Times - 10:02 AM PDT Thursday
Large Scale signs deal with BioCatalytics
Large Scale Biology Corp. and BioCatalytics Inc. have signed a multi-year collaboration and license agreement to develop improved enzymes for chemical synthesis.
Under terms of the deal BioCatalytics of Pasadena will pay a commercial license fee to Vacaville's Large Scale Biology (NASDAQ:LSBC) for use of its protein improvement technologies. Large Scale also will receive royalties on sales of products developed by BioCatalytics. Further details of the deal were not disclosed.
BioCatalytics believes the deal will yield a series of "next-generation" enzymes that can be used to make new chemical intermediates and drugs. Large Scale develops compounds and industrial proteins used in drug development and research.
East Bay Business Times
posted by Solano EDC at 10:31 AM
0 Comments:
Post a Comment
<< Home